Dr. Rakesh Srivastava

(Ph.D., MBA, FRSM , FRSPH)

Professor and President

Dr. Rakesh Srivastava (Ph.D., MBA, FRSM, FRSPH) is a name to reckon with when it comes to academics, research and medicine. He has been serving the field of sciences and has instilled several cornerstones in his decorated career of over 30 years. He is a true prodigy and has contributed immensely and meaningfully through his years of practice and teachings in the field of academics and sciences.

[coronavirus_notice]

Education

Fellowship

1996 - 1999

National Research Council, National Academy of Sciences.
Postdoctoral Fellow.

1994 - 1996

National Cancer Institute, National Institutes of Health, Bethesda, MD
Ph.D.

1991 - 1994

University of Guelph, Ontario, Canada
MBA

2020 - 2022

Tulane University New Orleans, Louisiana
M.Sc.

1988 - 1990

Memorial University of Newfoundland, St. John's, Newfoundland, Canada

APPOINTMENTS

President

2020 - Present -

GLAX Health, Dover, Wilmington
Scientific Director

2018-2020 -

GLAX Health, Dover, Wilmington
Professor

2016 - 2019 -

Stanley S. Scott Cancer Center, and Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA
Professor

2015 - 2016 -

Division of Pharmacology, University of Missouri-Kansas City, MO
Senior Scientist

2013 - 2016 -

Kansas City VA Medical Center, Kansas City, MO
Eminent Scholar

2009 – 2014 -

Kansas Bioscience Authority
Tyler Endowed Professor

2009 - 2014 -

Dept. of Pharmacology, Toxicology and Therapeutics, and Medicine, University of Kansas Medical Center, Kansas City, KS
Professor

2008 - 2009 -

Department of Biochemistry, University of Texas Health Science Center at Tyler, TX
Associate Professor

2005 - 2008 -

Department of Biochemistry, University of Texas Health Science Center at Tyler, TX
Assistant Professor

1999 - 2005 -

Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD